Population
In vivo model studying pre-mRNA splicing
Design
Preclinical
Authors
Loading...
Animal data link CPSF inhibition to defective single-intron splicing; leaves open validation and therapeutic targeting in mammalian systems.
The 3'-end-processing factor CPSF is required for the splicing of single-intron pre-mRNAs in vivo.
Li et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: